In situ T-cell responses in a primary regressive melanoma and subsequent metastases: A comparative analysis

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 241-247

  Carcelain, Guislaine ^a   Rouas Freiss, Nathalie ^b   Zorn, Emmanuel ^a   Chung Scott, Véronique ^b   Viel, Sophie ^b   Faure, Florence ^b   Bosq, Jacques ^b   Hercend, Thierry ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

AGED; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; AXILLARY LYMPH NODE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; NEOPLASM REGRESSION, SPONTANEOUS; SKIN NEOPLASMS; STOMACH NEOPLASMS;

EID: 0030787914     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<241::AID-IJC7>3.0.CO;2-R     Document Type: Article

References (20)

1. BRODSKY, F.M. and PARHAM, P., Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular sub-units and combinatorial determinants. J. Immunol. 128, 129-135 (1982).
2. BURNET, F.M., The concept of immunological surveillance. Prog. exp. Tumor Res., 13, 1-27 (1970).
3. DUNN, D.A., GADENNE, A.S., SIMHA, S., LERNER, E.A., BIGBY, M. and BLEICHER, P.A., T-cell-receptor Vβ expression in normal human skin. Proc. natr. Acad. Sci. (Wash.), 90, 1267-1271 (1993).
4. FERRADINI, L., MACKENSEN, A., GENEVEE, C., BOSQ, J., DUVILLARD, P., AVRIL, M.F. and HERCEND, T., Analysis of T-cell-receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma: evidence for in situ T-cell clonal expansion. J. clin. Invest., 91, 1183-1190 (1993).
5. FERRADINI, L., ROMAN-ROMAN, S., AZOCAR, J., AVRIL, M.F., VIEL, S., TRIEBEL, F. and HERCEND, T., Analysis of T-cell receptor α/β variability in lymphocytes infiltrating a melanoma metastasis. Cancer Res., 52, 4649-4654 (1992).
6. FERRONE, S. and MARINCOLA, F.M., Loss of HLA-class-I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 16, 487-494 (1995).
7. GAUGLER, B., BROUWENSTIJN, N., VANTOMME, V., SZIKORA, J.P., VAN DER SPEK, C., PATARD, J.J., BOON, T., SCHRIER, P. and VAN DEN EYNDE, B., A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on human renal carcinoma. Immunogenetics, 44, 323-330 (1996).
8. GENEVEE, C., DIU, A., VIERAT, J., CAIGNARD, A., DIETRICH, P.Y., FERRADINI, L., ROMAN-ROMAN, S., TRIEBEL, F. and HERCEND, T., An experimentally validated panel of sub-family-specific oligonucleotide primers (Vαl-w29/Vβ1-w24) for the study of human T-cell-receptor variable V gene segment usage by polymerase chain reaction. Europ. J. Immunol., 22, 1261-1269 (1992).
9. HERCEND, T., REINHERZ, E.L., MEUER, S., SCHLOSSMAN, S.F. and RITZ, J., Phenotypic and functional heterogeneity of human cloned natural-killer cell lines. Nature (Lond.), 301, 158-160 (1983).
10. HOLTON, T.A. and GRAHAM, M.W., A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors. Nucleic. Acids. Res., 19, 1156 (1990).
11. MACKENSEN, A., CARCELAIN, G., VIEL, S., RAYNAL, M.C., MICHALAKI, H., TRIEBEL, F., BOSQ, J. and HERCEND, T., Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. clin. Invest., 93, 1397-1402 (1994).
12. MACKENSEN, A., FERRADINI, L., CARCELAIN, G., TRIEBEL, F., FAURE, F., VIEL, S. and HERCEND, T., Evidence for in situ amplification of cytotoxic T-lymphocytes with anti-tumor activity in a human regressive melanoma. Cancer Res., 53, 3569-3573 (1993).
13. MCGOVERN, V.J., Spontaneous regression of melanoma. Pathology, 7, 91-99 (1975).
14. NATALI, P.G., IMAI, K., WILSON, B.S., BIGOTTI, A., CAVALIERI, R., PELLEGINO, M.A. and FERRONE, S., Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40s to human melanoma cells. J. nat. Cancer Inst., 76, 591-604s (601) (1981).
15. ROBBINS, P.F. and KAWAKAMI, Y., Human tumor antigens recognized by T cells. Curr. Opin. Immunol., 8, 628-636 (1996).
16. ROSENBERG, S.A., LOTZE, M.T., YANG, J.C., AEBERSOLD, P.M., LINEHAN, W.M., SEIPP, C.A. and WHITE, D.E., Experience with the use of high-dose interleukine-2 in the treatment of 652 cancer patients. Ann. Surg., 210, 474-485 (1989).
17. SENSI, M. and PARMIANI, G., Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today, 16, 588-595 (1995).
18. TEFANY, F.J., BARNETSON, R. ST C., HALLIDAY, G.M. and MC CARTHY, W.H., Immunocytochemical analysis of the cellular infiltrate in primary regressins and non-regressing malignant melanoma. J. invest. Dermatol., 97, 197-202 (1991).
19. TODD, R.F., MEUER, S.C., ROMAIN, P.L. and SCHLOSSMAN, S.F., A monoclonal antibody that blocks class-II-histocompatibility-related immune interactions. Hum. Immunol., 10, 23-40 (1994).
20. TOPALIAN, S.L., SALOMON, D. and ROSENBERG, S.A., Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol., 142, 3714-3725 (1989).